These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21775700)

  • 1. The complete automation of cell culture: improvements for high-throughput and high-content screening.
    Jain S; Sondervan D; Rizzu P; Bochdanovits Z; Caminada D; Heutink P
    J Biomol Screen; 2011 Sep; 16(8):932-9. PubMed ID: 21775700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From single genes to gene networks: high-throughput-high-content screening for neurological disease.
    Jain S; Heutink P
    Neuron; 2010 Oct; 68(2):207-17. PubMed ID: 20955929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput RNAi screening for the identification of novel targets.
    Henderson MC; Azorsa DO
    Methods Mol Biol; 2013; 986():89-95. PubMed ID: 23436407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pluripotent stem cells: the development of high-content screening strategies.
    Sherman SP; Alva JA; Thakore-Shah K; Pyle AD
    Methods Mol Biol; 2011; 767():283-95. PubMed ID: 21822883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-content screening of functional genomic libraries.
    Rines DR; Tu B; Miraglia L; Welch GL; Zhang J; Hull MV; Orth AP; Chanda SK
    Methods Enzymol; 2006; 414():530-65. PubMed ID: 17110210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular phenotype recognition for high-content RNA interference genome-wide screening.
    Wang J; Zhou X; Bradley PL; Chang SF; Perrimon N; Wong ST
    J Biomol Screen; 2008 Jan; 13(1):29-39. PubMed ID: 18227224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA libraries.
    Swearingen EA; Fajardo F; Wang X; Watson JE; Quon KC; Kassner PD
    J Biomol Screen; 2010 Jun; 15(5):469-77. PubMed ID: 20371867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live cell imaging: an industrial perspective.
    McCann T
    Methods Mol Biol; 2010; 591():47-66. PubMed ID: 19957123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The automated cell: compound and environment screening system (ACCESS) for chemogenomic screening.
    Proctor M; Urbanus ML; Fung EL; Jaramillo DF; Davis RW; Nislow C; Giaever G
    Methods Mol Biol; 2011; 759():239-69. PubMed ID: 21863492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screens using RNAi and cDNA expression as surrogates for genetics in mammalian tissue culture cells.
    Pearlberg J; Degot S; Endege W; Park J; Davies J; Gelfand E; Sawyer J; Conery A; Doench J; Li W; Gonzalez L; Boyce FM; Brizuela L; Labaer J; Grueneberg D; Harlow E
    Cold Spring Harb Symp Quant Biol; 2005; 70():449-59. PubMed ID: 16869783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of automatic high-resolution light microscopy for cell-based screens.
    Paran Y; Lavelin I; Naffar-Abu-Amara S; Winograd-Katz S; Liron Y; Geiger B; Kam Z
    Methods Enzymol; 2006; 414():228-47. PubMed ID: 17110195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput RNA interference strategies for target discovery and validation by using synthetic short interfering RNAs: functional genomics investigations of biological pathways.
    Sachse C; Krausz E; Krönke A; Hannus M; Walsh A; Grabner A; Ovcharenko D; Dorris D; Trudel C; Sönnichsen B; Echeverri CJ
    Methods Enzymol; 2005; 392():242-77. PubMed ID: 15644186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a high-throughput and automated cancer cell proliferation panel for oncology lead optimization.
    Lei M; Ribeiro H; Kolodin G; Gill J; Wang YS; Maloney D; Fan Y; Li S; Myer L; Beluch M; Zhang L; Schweizer L
    J Biomol Screen; 2013 Oct; 18(9):1043-53. PubMed ID: 23733846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
    Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
    Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of automated cell-based protocols for toxicity testing of biomaterials.
    Ferreira MV; Jahnen-Dechent W; Neuss S
    J Biomol Screen; 2011 Jul; 16(6):647-54. PubMed ID: 21518824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated sample area definition for high-throughput microscopy.
    Zeder M; Ellrott A; Amann R
    Cytometry A; 2011 Apr; 79(4):306-10. PubMed ID: 21412981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning improves the precision and robustness of high-content screens: using nonlinear multiparametric methods to analyze screening results.
    Horvath P; Wild T; Kutay U; Csucs G
    J Biomol Screen; 2011 Oct; 16(9):1059-67. PubMed ID: 21807964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and validation of DNA synthesis detection by fluorescent dye derivatization for high-throughput screening.
    Ranall MV; Gabrielli BG; Gonda TJ
    Biotechniques; 2010 May; 48(5):379-86. PubMed ID: 20569211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Median absolute deviation to improve hit selection for genome-scale RNAi screens.
    Chung N; Zhang XD; Kreamer A; Locco L; Kuan PF; Bartz S; Linsley PS; Ferrer M; Strulovici B
    J Biomol Screen; 2008 Feb; 13(2):149-58. PubMed ID: 18216396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High content screening in neurodegenerative diseases.
    Jain S; van Kesteren RE; Heutink P
    J Vis Exp; 2012 Jan; (59):e3452. PubMed ID: 22257990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.